chloroquine has been researched along with glutaminase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Addie, RD; Bovée, JVMG; Cleton-Jansen, AM; Cleven, AHG; de Jong, Y; Kruisselbrink, AB; Molenaar, RJ; Niessen, B; Peterse, EFP; van den Akker, BEWM | 1 |
| Bhagwat, AM; Dib, SS; Elemento, O; Gross, SS; Halama, A; Iskandarani, A; Kastenmüller, G; Kulinski, M; Prabhu, KS; Satheesh, NJ; Siveen, KS; Suhre, K; Uddin, S; Zaghlool, SB; Zierer, J | 1 |
2 other study(ies) available for chloroquine and glutaminase
| Article | Year |
|---|---|
Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation.
Topics: Antineoplastic Agents; Benzeneacetamides; Bone Neoplasms; Chloroquine; Chondrosarcoma; Drug Screening Assays, Antitumor; Glutaminase; Glutamine; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Metabolic Networks and Pathways; Metformin; Molecular Targeted Therapy; Mutation; Neoplasm Grading; Thiadiazoles; Tumor Cells, Cultured | 2018 |
Accelerated lipid catabolism and autophagy are cancer survival mechanisms under inhibited glutaminolysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Benzophenanthridines; Cell Line, Tumor; Cell Proliferation; Chloroquine; Glutaminase; Glutamine; Humans; Lipolysis; Metabolomics; Neoplasms; Oxidative Stress | 2018 |